Renal Cancer - Results from #3440

Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial. July 19, 2019

Tropomyosin-1 Functions as a Tumor Suppressor with Respect to Cell Proliferation, Angiogenesis and Metastasis in Renal Cell Carcinoma. July 19, 2019

The evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma. July 18, 2019

Systematic expression analysis of the mitochondrial respiratory chain protein subunits identifies COX5B as a prognostic marker in clear cell renal cell carcinoma. July 18, 2019

Renal cell carcinomas with a mesenchymal stromal component: what do we know so far? July 18, 2019

Chromophobe Renal Cell Carcinoma Presenting as a Cystic Renal Mass: Case Report and Review of the Literature. July 17, 2019

The clinical significance of PYCR1 expression in renal cell carcinoma. July 17, 2019

Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies. July 17, 2019

Dataset for the reporting of renal biopsy for tumour: recommendations from the International Collaboration on Cancer Reporting (ICCR). July 16, 2019

Trends in surgical and ablative treatment of localised renal cell carcinoma: A review of publication trends over 16 years (2000-2015). July 16, 2019

Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma. July 16, 2019

Clinical Stage Migration and Survival for Renal Cell Carcinoma in the United States. July 15, 2019

Overexpression of miR-15b Promotes Resistance to Sunitinib in Renal Cell Carcinoma. July 15, 2019

Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy Audit. July 15, 2019

miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer. July 12, 2019

Positive margins after partial nephrectomy in renal cell carcinoma: Oncological outcomes of conservative management after long-term follow-up. July 12, 2019

Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal Cancer Patients with Sunitinib and Sorafenib. July 12, 2019

Prognostic significance of VHL, HIF1A, HIF2A, VEGFA and p53 expression in patients with clear‑cell renal cell carcinoma treated with sunitinib as first‑line treatment. July 11, 2019

Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data. July 11, 2019

Diabetes and kidney cancer survival in patients undergoing nephrectomy: A Canadian multi-center, propensity score analysis. July 11, 2019

Page 173 of 456